Intravenous immunoglobulin in children with Guillain-Barré syndrome
Autor(es): Bruck I, Antoniuk S A, Cat R, Spessatto A, Halick S M, Bruyn L R, Rodrigues M, Scola R H, Werneck L C
Resumo: We report our experience with intravenous immunoglobulin (IVIG), plasmapheresis and supportive care in 13 patients with the Guillain-Barré syndrome. Seven of 13 patients received IVIG, 2 plasmapheresis and 4 supportive care. At 15th day after IVIG administration, all patients in this group had improved at least one disability grade. In the plasmapheresis group, 1 improved at 5th day after the procedure. Two of the 4 patients that received supportive care improved at 20th day of evaluation. In the IVIG group, the final scores were lower and had no relapses. These results suggest faster clinical improvement with IVIG when compared with supportive measures.
Imprenta: Arquivos de Neuro-Psiquiatria, v. 58, n. 4, p. 1081-1091, 2000
Identificador do objeto digital: 10.1590/S0004-282X2000000600016
Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Public health
Data de publicação: 2000
